ESSA Pharma (EPIX) News Today → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free EPIX Stock Alerts $6.12 -0.13 (-2.08%) (As of 04:00 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCritical Review: Eli Lilly and Company (NYSE:LLY) & ESSA Pharma (NASDAQ:EPIX)americanbankingnews.com - April 16 at 2:40 AMShort Interest in ESSA Pharma Inc. (NASDAQ:EPIX) Drops By 13.5%marketbeat.com - April 14 at 8:16 PMESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conferencefinance.yahoo.com - April 9 at 8:33 AMESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conferenceprnewswire.com - April 9 at 8:00 AMESSA Pharma (NASDAQ:EPIX) Is In A Strong Position To Grow Its Businessfinance.yahoo.com - April 8 at 3:40 PMEssa Pharma COO sells shares worth over $5,500investing.com - April 7 at 12:40 PMESSA Pharma Inc EPIXmorningstar.com - April 5 at 8:57 PMESSA Pharma Inc. (NASDAQ:EPIX) Short Interest Updatemarketbeat.com - March 16 at 6:46 PMEPIX Jul 2024 7.500 callfinance.yahoo.com - March 10 at 1:42 PMEPIX Jul 2024 12.500 putfinance.yahoo.com - March 10 at 1:42 PMESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERSprnewswire.com - March 7 at 8:13 PMShort Interest in ESSA Pharma Inc. (NASDAQ:EPIX) Grows By 5.2%marketbeat.com - February 16 at 11:31 AMESSA Pharma (NASDAQ:EPIX) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPSmarketbeat.com - February 14 at 9:27 AMESSA Pharma: Q1 Earnings Insightsbenzinga.com - February 13 at 2:14 PMESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023finance.yahoo.com - February 13 at 9:13 AMESSA Pharma Inc. (NASDAQ:EPIX) Shares Sold by Rhenman & Partners Asset Management ABmarketbeat.com - February 12 at 1:00 PMESSA Pharma Inc Executive Peter Virsik Sells 72,782 Sharesfinance.yahoo.com - February 8 at 12:15 AMESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - February 6 at 9:15 AMESSA Pharma Inc.'s (NASDAQ:EPIX) hedge funds investors lost 12% last week but have benefitted from longer-term gainsfinance.yahoo.com - January 22 at 9:58 AMZacks Small Cap Comments on ESSA Pharma Inc.'s Q1 2024 Earnings (NASDAQ:EPIX)marketbeat.com - December 22 at 6:52 AMEPIX: Initial Data from Combination Trial of Masofaniten and Enzalutamide Expected in 2024…finance.yahoo.com - December 20 at 5:36 PMESSA Pharma Inc. (NASDAQ:EPIX) CEO David Ross Parkinson Acquires 9,223 Sharesmarketbeat.com - December 19 at 9:16 AMESSA Pharma Stock (NASDAQ:EPIX) Earnings Dates and Earning Callsbenzinga.com - December 14 at 6:00 PMJefferies Financial Group Raises ESSA Pharma (NASDAQ:EPIX) Price Target to $16.00marketbeat.com - December 13 at 2:12 PMESSA Pharma (NASDAQ:EPIX) Announces Earnings Results, Beats Estimates By $0.10 EPSmarketbeat.com - December 13 at 8:52 AMESSA Pharma Stock (NASDAQ:EPIX) Dividends: History, Yield and Datesbenzinga.com - December 12 at 11:07 PMRecap: ESSA Pharma Q4 Earningsbenzinga.com - December 12 at 1:07 PMESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023finance.yahoo.com - December 12 at 8:07 AMBullish ESSA Pharma Insiders Loaded Up On US$1.19m Of Stockfinance.yahoo.com - December 11 at 9:40 AMESSA Pharma director Franklin Berger buys common shares worth ~$133.3Kmsn.com - November 24 at 11:58 AMESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conferencefinance.yahoo.com - November 21 at 10:18 AMESSA Pharma to Present at the Jefferies London Healthcare Conferencefinance.yahoo.com - November 8 at 9:32 AMWe Think ESSA Pharma (NASDAQ:EPIX) Can Afford To Drive Business Growthfinance.yahoo.com - October 31 at 2:38 PMEPIX: Dose Escalation Data for Combination of Masofaniten (EPI-7386) and Enzalutamide Presented at PCF Retreat…finance.yahoo.com - October 30 at 3:37 PMESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the European Society of Medical Oncology 2023 Congressfinance.yahoo.com - October 21 at 1:27 PMESSA Pharma Inc. (NASDAQ:EPIX) Sees Large Decline in Short Interestmarketbeat.com - September 15 at 8:26 AMEPIX: Phase 2 Trial of EPI-7386 in Combination with Enzalutamide to Initiate in Calendar 3Q23…finance.yahoo.com - August 14 at 3:20 PMESSA Pharma Inc. (NASDAQ:EPIX) is definitely on the radar of hedge funds investors who own 39% of the companyfinance.yahoo.com - August 14 at 10:04 AMESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2023finance.yahoo.com - August 8 at 8:17 AMESSA Pharma Appoints Lauren Merendino to its Board of Directorsfinance.yahoo.com - June 6 at 9:14 AMESSA Pharma to Present at 2023 Jefferies Healthcare Conferencefinance.yahoo.com - June 1 at 10:23 AMWe're Hopeful That ESSA Pharma (NASDAQ:EPIX) Will Use Its Cash Wiselyfinance.yahoo.com - May 24 at 4:47 PMEPIX: Moving Towards Phase 2 Trial of EPI-7386 in Combination with Enzalutamide…finance.yahoo.com - May 18 at 12:49 PMESSA Pharma to Present at JMP Securities Life Sciences Conferencefinance.yahoo.com - May 11 at 9:38 AMESSA Pharma: Q2 Earnings Insightsmsn.com - May 9 at 3:23 PMESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2023finance.yahoo.com - May 9 at 10:23 AMFrazier Life Sciences Management L.P. Has $1.53 Million Stock Position in ESSA Pharma Inc. (NASDAQ:EPIX)marketbeat.com - May 1 at 5:21 AMESSA Pharma to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conferencefinance.yahoo.com - April 18 at 8:59 AMESSA Pharma Inc. (EPIX)ca.finance.yahoo.com - April 15 at 3:44 PMESSA Pharma Announces Clinical Trial Support Agreement with Janssen to Evaluate EPI-7386 Combinations in Patients with Prostate Cancerfinance.yahoo.com - April 12 at 9:35 AM Get ESSA Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter. Email Address World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea. Click here to find out what to do. EPIX Media Mentions By Week EPIX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EPIX News Sentiment▼0.000.42▲Average Medical News Sentiment EPIX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EPIX Articles This Week▼00▲EPIX Articles Average Week Get ESSA Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Akebia Therapeutics News Werewolf Therapeutics News RAPT Therapeutics News Enanta Pharmaceuticals News Vanda Pharmaceuticals News Renovaro News Verrica Pharmaceuticals News Erasca News Nanobiotix News Neoleukin Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EPIX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ESSA Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
